Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Last updated on 2019-06-19 History
Report ID 47356
Drug Identification Number 02461412
Brand name MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Common or Proper name EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 600MG 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-11
Actual start date
Estimated end date 2019-06-21
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2018-10-23 French Compare
v22 2018-11-06 English Compare
v23 2018-11-06 French Compare
v24 2018-11-13 English Compare
v25 2018-11-13 French Compare
v26 2018-11-13 English Compare
v27 2018-11-13 French Compare
v28 2018-11-20 English Compare
v29 2018-11-20 French Compare
v30 2018-11-30 English Compare
v31 2018-11-30 French Compare
v32 2018-12-05 English Compare
v33 2018-12-05 French Compare
v34 2019-01-02 English Compare
v35 2019-01-02 French Compare
v36 2019-01-08 English Compare
v37 2019-01-08 French Compare
v38 2019-02-21 English Compare
v39 2019-02-21 French Compare
v40 2019-03-05 English Compare

Showing 21 to 40 of 64